However, the analysis of CD4 mRNA in PBMC samples showed a particular immune profile for this transcript in AD samples (Figure 3B); specifically, CD4 mRNA levels were significantly increased in AD samples when comparing to the control group while in the case of MCI samples, only a tendency to increase was appreciated. This evidence concerns the gene CD4 and Alzheimer disease.